Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026)
Edgewise Therapeutics (EWTX) reported Prepaid Assets of $10.2 million for Q1 2026, up 50.64% on a YoY basis from $6.8 million in Q1 2025, and down 22.94% sequentially from $13.3 million in Q4 2025.
Edgewise Therapeutics (EWTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Edgewise Therapeutics (EWTX) has 7 years of Prepaid Assets data on file, last reported at $10.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 50.64% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (up 50.64% YoY), and the FY2025 full-year result was $13.3 million, up 149.88% from the prior year.
- Prepaid Assets declined to $10.2 million in Q1 2026, from $13.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.3 million in Q4 2025 to a low of $2.8 million in Q1 2022.
- A 5-year average of $7.4 million and a median of $7.1 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 313.06% in 2022 and sank 38.25% in 2024, its largest moves.
- Tracing EWTX's Prepaid Assets over 5 years: stood at $5.1 million in 2022, then soared by 70.31% to $8.6 million in 2023, then sank by 38.25% to $5.3 million in 2024, then surged by 149.88% to $13.3 million in 2025, then retreated by 22.94% to $10.2 million in 2026.
- Business Quant data shows EWTX's Prepaid Assets at $10.2 million in Q1 2026, $13.3 million in Q4 2025, and $10.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.23 Mn |
| Dec 31, 2025 | 13.28 Mn |
| Sep 30, 2025 | 10.56 Mn |
| Jun 30, 2025 | 9.26 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Sep 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | 7.69 Mn |
| Mar 31, 2024 | 8.67 Mn |
| Dec 31, 2023 | 8.60 Mn |
| Sep 30, 2023 | 8.22 Mn |
| Jun 30, 2023 | 7.07 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 5.05 Mn |
| Sep 30, 2022 | 5.32 Mn |
| Jun 30, 2022 | 4.95 Mn |
| Mar 31, 2022 | 2.78 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 3.82 Mn |